Armistice Capital Reports 9.99% Stake in INVO Fertility, Inc.

On May 15, 2026, Armistice Capital, LLC and its managing member, Steven Boyd, filed a Schedule 13G/A reporting a significant position in INVO Fertility, Inc. (Ticker: IVF). The filing indicates that the reporting persons beneficially own 371,562 shares of common stock, representing a 9.99% ownership stake in the company. This reflects a substantial increase from a previous reported position of zero shares. Armistice Capital serves as the investment manager for Armistice Capital Master Fund Ltd., which is the direct holder of the shares. Under the terms of their investment management agreement, Armistice Capital and Steven Boyd exercise shared voting and dispositive power over these securities. The filing specifies that these shares were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The event triggering this filing occurred on March 31, 2026.